1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Continuous Peripheral Nerve Block (CPNB) Catheters Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Continuous Peripheral Nerve Block (CPNB) Catheters by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Continuous Peripheral Nerve Block (CPNB) Catheters by Country/Region, 2020, 2024 & 2031
2.2 Continuous Peripheral Nerve Block (CPNB) Catheters Segment by Type
2.2.1 Ultrasound
2.2.2 Nerve Stimulation
2.3 Continuous Peripheral Nerve Block (CPNB) Catheters Sales by Type
2.3.1 Global Continuous Peripheral Nerve Block (CPNB) Catheters Sales Market Share by Type (2020-2025)
2.3.2 Global Continuous Peripheral Nerve Block (CPNB) Catheters Revenue and Market Share by Type (2020-2025)
2.3.3 Global Continuous Peripheral Nerve Block (CPNB) Catheters Sale Price by Type (2020-2025)
2.4 Continuous Peripheral Nerve Block (CPNB) Catheters Segment by Application
2.4.1 Ambulatory Surgical Centers
2.4.2 Hospitals
2.5 Continuous Peripheral Nerve Block (CPNB) Catheters Sales by Application
2.5.1 Global Continuous Peripheral Nerve Block (CPNB) Catheters Sale Market Share by Application (2020-2025)
2.5.2 Global Continuous Peripheral Nerve Block (CPNB) Catheters Revenue and Market Share by Application (2020-2025)
2.5.3 Global Continuous Peripheral Nerve Block (CPNB) Catheters Sale Price by Application (2020-2025)
3 Global Continuous Peripheral Nerve Block (CPNB) Catheters by Company
3.1 Global Continuous Peripheral Nerve Block (CPNB) Catheters Breakdown Data by Company
3.1.1 Global Continuous Peripheral Nerve Block (CPNB) Catheters Annual Sales by Company (2020-2025)
3.1.2 Global Continuous Peripheral Nerve Block (CPNB) Catheters Sales Market Share by Company (2020-2025)
3.2 Global Continuous Peripheral Nerve Block (CPNB) Catheters Annual Revenue by Company (2020-2025)
3.2.1 Global Continuous Peripheral Nerve Block (CPNB) Catheters Revenue by Company (2020-2025)
3.2.2 Global Continuous Peripheral Nerve Block (CPNB) Catheters Revenue Market Share by Company (2020-2025)
3.3 Global Continuous Peripheral Nerve Block (CPNB) Catheters Sale Price by Company
3.4 Key Manufacturers Continuous Peripheral Nerve Block (CPNB) Catheters Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Continuous Peripheral Nerve Block (CPNB) Catheters Product Location Distribution
3.4.2 Players Continuous Peripheral Nerve Block (CPNB) Catheters Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2025)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Continuous Peripheral Nerve Block (CPNB) Catheters by Geographic Region
4.1 World Historic Continuous Peripheral Nerve Block (CPNB) Catheters Market Size by Geographic Region (2020-2025)
4.1.1 Global Continuous Peripheral Nerve Block (CPNB) Catheters Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Continuous Peripheral Nerve Block (CPNB) Catheters Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Continuous Peripheral Nerve Block (CPNB) Catheters Market Size by Country/Region (2020-2025)
4.2.1 Global Continuous Peripheral Nerve Block (CPNB) Catheters Annual Sales by Country/Region (2020-2025)
4.2.2 Global Continuous Peripheral Nerve Block (CPNB) Catheters Annual Revenue by Country/Region (2020-2025)
4.3 Americas Continuous Peripheral Nerve Block (CPNB) Catheters Sales Growth
4.4 APAC Continuous Peripheral Nerve Block (CPNB) Catheters Sales Growth
4.5 Europe Continuous Peripheral Nerve Block (CPNB) Catheters Sales Growth
4.6 Middle East & Africa Continuous Peripheral Nerve Block (CPNB) Catheters Sales Growth
5 Americas
5.1 Americas Continuous Peripheral Nerve Block (CPNB) Catheters Sales by Country
5.1.1 Americas Continuous Peripheral Nerve Block (CPNB) Catheters Sales by Country (2020-2025)
5.1.2 Americas Continuous Peripheral Nerve Block (CPNB) Catheters Revenue by Country (2020-2025)
5.2 Americas Continuous Peripheral Nerve Block (CPNB) Catheters Sales by Type
5.3 Americas Continuous Peripheral Nerve Block (CPNB) Catheters Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Continuous Peripheral Nerve Block (CPNB) Catheters Sales by Region
6.1.1 APAC Continuous Peripheral Nerve Block (CPNB) Catheters Sales by Region (2020-2025)
6.1.2 APAC Continuous Peripheral Nerve Block (CPNB) Catheters Revenue by Region (2020-2025)
6.2 APAC Continuous Peripheral Nerve Block (CPNB) Catheters Sales by Type
6.3 APAC Continuous Peripheral Nerve Block (CPNB) Catheters Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Continuous Peripheral Nerve Block (CPNB) Catheters by Country
7.1.1 Europe Continuous Peripheral Nerve Block (CPNB) Catheters Sales by Country (2020-2025)
7.1.2 Europe Continuous Peripheral Nerve Block (CPNB) Catheters Revenue by Country (2020-2025)
7.2 Europe Continuous Peripheral Nerve Block (CPNB) Catheters Sales by Type
7.3 Europe Continuous Peripheral Nerve Block (CPNB) Catheters Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Continuous Peripheral Nerve Block (CPNB) Catheters by Country
8.1.1 Middle East & Africa Continuous Peripheral Nerve Block (CPNB) Catheters Sales by Country (2020-2025)
8.1.2 Middle East & Africa Continuous Peripheral Nerve Block (CPNB) Catheters Revenue by Country (2020-2025)
8.2 Middle East & Africa Continuous Peripheral Nerve Block (CPNB) Catheters Sales by Type
8.3 Middle East & Africa Continuous Peripheral Nerve Block (CPNB) Catheters Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Continuous Peripheral Nerve Block (CPNB) Catheters
10.3 Manufacturing Process Analysis of Continuous Peripheral Nerve Block (CPNB) Catheters
10.4 Industry Chain Structure of Continuous Peripheral Nerve Block (CPNB) Catheters
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Continuous Peripheral Nerve Block (CPNB) Catheters Distributors
11.3 Continuous Peripheral Nerve Block (CPNB) Catheters Customer
12 World Forecast Review for Continuous Peripheral Nerve Block (CPNB) Catheters by Geographic Region
12.1 Global Continuous Peripheral Nerve Block (CPNB) Catheters Market Size Forecast by Region
12.1.1 Global Continuous Peripheral Nerve Block (CPNB) Catheters Forecast by Region (2026-2031)
12.1.2 Global Continuous Peripheral Nerve Block (CPNB) Catheters Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Continuous Peripheral Nerve Block (CPNB) Catheters Forecast by Type
12.7 Global Continuous Peripheral Nerve Block (CPNB) Catheters Forecast by Application
13 Key Players Analysis
13.1 B. Braun Melsungen AG
13.1.1 B. Braun Melsungen AG Company Information
13.1.2 B. Braun Melsungen AG Continuous Peripheral Nerve Block (CPNB) Catheters Product Portfolios and Specifications
13.1.3 B. Braun Melsungen AG Continuous Peripheral Nerve Block (CPNB) Catheters Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 B. Braun Melsungen AG Main Business Overview
13.1.5 B. Braun Melsungen AG Latest Developments
13.2 Teleflex Incorporated
13.2.1 Teleflex Incorporated Company Information
13.2.2 Teleflex Incorporated Continuous Peripheral Nerve Block (CPNB) Catheters Product Portfolios and Specifications
13.2.3 Teleflex Incorporated Continuous Peripheral Nerve Block (CPNB) Catheters Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teleflex Incorporated Main Business Overview
13.2.5 Teleflex Incorporated Latest Developments
13.3 Halyard Health, Inc
13.3.1 Halyard Health, Inc Company Information
13.3.2 Halyard Health, Inc Continuous Peripheral Nerve Block (CPNB) Catheters Product Portfolios and Specifications
13.3.3 Halyard Health, Inc Continuous Peripheral Nerve Block (CPNB) Catheters Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Halyard Health, Inc Main Business Overview
13.3.5 Halyard Health, Inc Latest Developments
13.4 Pajunk GmbH
13.4.1 Pajunk GmbH Company Information
13.4.2 Pajunk GmbH Continuous Peripheral Nerve Block (CPNB) Catheters Product Portfolios and Specifications
13.4.3 Pajunk GmbH Continuous Peripheral Nerve Block (CPNB) Catheters Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pajunk GmbH Main Business Overview
13.4.5 Pajunk GmbH Latest Developments
13.5 Epimed International
13.5.1 Epimed International Company Information
13.5.2 Epimed International Continuous Peripheral Nerve Block (CPNB) Catheters Product Portfolios and Specifications
13.5.3 Epimed International Continuous Peripheral Nerve Block (CPNB) Catheters Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Epimed International Main Business Overview
13.5.5 Epimed International Latest Developments
13.6 Ace Medical
13.6.1 Ace Medical Company Information
13.6.2 Ace Medical Continuous Peripheral Nerve Block (CPNB) Catheters Product Portfolios and Specifications
13.6.3 Ace Medical Continuous Peripheral Nerve Block (CPNB) Catheters Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ace Medical Main Business Overview
13.6.5 Ace Medical Latest Developments
13.7 Vygon
13.7.1 Vygon Company Information
13.7.2 Vygon Continuous Peripheral Nerve Block (CPNB) Catheters Product Portfolios and Specifications
13.7.3 Vygon Continuous Peripheral Nerve Block (CPNB) Catheters Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Vygon Main Business Overview
13.7.5 Vygon Latest Developments
14 Research Findings and Conclusion
※参考情報 連続末梢神経ブロック(CPNB)カテーテルは、末梢神経ブロックを持続的に行うための医療機器であり、主に鎮痛管理の目的で使用されます。この技術は、手術後の疼痛管理や慢性疼痛の治療において、その効果と重要性が広く認識されています。ここでは、CPNBカテーテルについての概念、特徴、種類、用途、関連技術について詳しく説明いたします。 CPNBカテーテルの定義は、特定の末梢神経に対して局所麻酔薬を持続的に投与するためのカテーテルを指します。このカテーテルは、通常、手術後の痛みを軽減するために設置され、特定の神経をターゲットとして痛みの信号を遮断します。これにより、患者はより快適なリカバリーを経験することができ、痛みの管理が促進されます。 CPNBカテーテルの主な特徴としては、まず、その持続的な薬剤投与が挙げられます。これにより、患者は必要に応じて適切な鎮痛を継続的に受けることができ、急性の痛みの管理において有効性を発揮します。また、カテーテルの設置によって、薬剤の投与量や配分を細かく調整することが可能となり、個々の患者のニーズに合わせたカスタマイズが行えます。この柔軟性は、他の鎮痛方法に比べて大きなメリットとなります。 CPNBカテーテルの種類は、主に神経ブロックを行う対象とする神経に基づいて分類されます。例えば、膝関節手術後の痛み管理には大腿神経ブロックが一般的に使用されることが多く、また上肢の手術後には鎖骨下神経ブロックが選ばれることがあります。これらの神経ブロックにはそれぞれ対応するカテーテルの種類があり、医師が患者の状態や手術内容に応じて選択することが重要です。 CPNBカテーテルの用途は多岐にわたり、最も一般的なものは手術後の鎮痛管理です。特に整形外科手術、胸部手術、腹部手術など、さまざまな外科手術後の疼痛を軽減するために使用されます。さらに、慢性疼痛症候群を有する患者や癌性疼痛の緩和にも利用されることがあります。これにより、患者は痛みの軽減に伴い、早期のリハビリテーションや日常生活への復帰が促進されます。 関連技術には、超音波ガイド下神経ブロックが存在します。これは、カテーテルの挿入位置を正確に確認できるため、より安全で効果的な神経ブロックを実現します。この技術の進歩により、カテーテルの挿入精度が向上し、合併症のリスクが低下することが期待されています。また、近年ではポンプによる自動投与システムも普及しており、患者自身が痛みの程度に応じて薬剤を調整できる仕組みもあります。これにより、患者の痛みのコントロールがさらに向上します。 CPNBカテーテルの利点には、疼痛の持続的な管理が可能であること、入院期間の短縮、鎮痛薬の全身的な副作用を軽減することなどがあります。一方で、カテーテル使用に伴う合併症としては、感染、血腫、神経損傷などが挙げられます。しかし、これらのリスクを管理し、慎重に使用することで、CPNBの利点を最大限に引き出すことが可能です。 CPNBカテーテルはその効果的な疼痛管理手法として、多くの医療現場で採用されており、患者の療養環境を大幅に改善する役割を果たしています。今後も技術の進歩に伴い、より安全で効果的な鎮痛管理が実現されることが期待されています。このように、CPNBカテーテルは現代医学における重要な治療法の一つであると言えます。患者の生活の質の向上に寄与するため、今後も研究や実践が続けられるでしょう。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/